Literature DB >> 15844697

Attitudes and referral patterns of primary care physicians when evaluating subjects with noncardiac chest pain--a national survey.

Wai-Man Wong1, Joy Beeler, Sara Risner-Adler, Sara Habib, Jimmy Bautista, Ronnie Fass.   

Abstract

Noncardiac chest pain (NCCP) may affect up to 23% of the U.S. population. The clinical approach and referral patterns of primary care physicians (PCPs) when evaluating NCCP subjects are unknown. We aimed to determine the preferences of diagnostic tests, referral patterns, and treatment plans of NCCP patients by PCPs. PCPs were randomly selected from the American Medical Association national membership list. A 24-item questionnaire was mailed, which focused on demographic information, characteristics of practice, preferences of diagnostic tests, referral patterns, and treatment plans. Two hundred five (40%) PCPs returned the questionnaire (mean age, 49; 77% males; practice type--community-based, 40.5%; hospital-based, 10.7%; and combined, 47.3%; physician type--internists, 46.3%; family physicians, 44.4%; general practitioners, 4.9%; and others, 2.9%). The mean number of NCCP patients seen in the past 6 months was 108 (6.4% of total patients) and 79.5% were treated primarily by PCPs. The three most common diagnostic tests used were empirical proton pump inhibitor (PPI) trial (45.6%), chest radiograph (39.9%), and upper endoscopy (18.7%). Most PCPs reported that they are either comfortable (44.6%) or very comfortable (21.2%) in diagnosing NCCP. The three most commonly used therapeutic modalities for NCCP were PPIs (37.8%), lifestyle modification (33.7%), and H2 blockers (12.4%). Of those NCCP patients referred to a subspecialist, most ended up in gastroenterology (75.6%), followed by cardiology (7.8%) and pulmonary (1.6%) clinics. We conclude that most PCP's diagnose and treat NCCP patients without referring them to a gastroenterologist. However, diagnostic and treatment strategies may not follow the current understanding and knowledge of the disorder.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15844697     DOI: 10.1007/s10620-005-2552-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Long-term outcome from tricyclic antidepressant treatment of functional chest pain.

Authors:  C Prakash; R E Clouse
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

2.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

Review 3.  Review article: visceral hypersensitivity.

Authors:  H Mertz
Journal:  Aliment Pharmacol Ther       Date:  2003-03-01       Impact factor: 8.171

4.  Twenty-four-hour esophageal pH monitoring: the most useful test for evaluating noncardiac chest pain.

Authors:  E G Hewson; J W Sinclair; C B Dalton; J E Richter
Journal:  Am J Med       Date:  1991-05       Impact factor: 4.965

5.  Chest pain of esophageal origin.

Authors:  Ronnie Fass
Journal:  Curr Opin Gastroenterol       Date:  2002-07       Impact factor: 3.287

6.  Abnormal sensory perception in patients with esophageal chest pain.

Authors:  J E Richter; C F Barish; D O Castell
Journal:  Gastroenterology       Date:  1986-10       Impact factor: 22.682

7.  Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial.

Authors:  R E Clouse; P J Lustman; T C Eckert; D M Ferney; L S Griffith
Journal:  Gastroenterology       Date:  1987-04       Impact factor: 22.682

8.  Diagnosis and treatment of patients with gastroesophageal reflux and noncardiac chest pain.

Authors:  W G Stahl; R R Beton; C S Johnson; C L Brown; J P Waring
Journal:  South Med J       Date:  1994-07       Impact factor: 0.954

9.  The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain.

Authors:  R Fass; M B Fennerty; J J Ofman; I M Gralnek; C Johnson; E Camargo; R E Sampliner
Journal:  Gastroenterology       Date:  1998-07       Impact factor: 22.682

Review 10.  Esophageal chest pain: current controversies in pathogenesis, diagnosis, and therapy.

Authors:  J E Richter; L A Bradley; D O Castell
Journal:  Ann Intern Med       Date:  1989-01-01       Impact factor: 25.391

View more
  6 in total

Review 1.  Non-cardiac Chest Pain: A Review for the Consultation-Liaison Psychiatrist.

Authors:  Kirsti A Campbell; Elizabeth N Madva; Ana C Villegas; Eleanor E Beale; Scott R Beach; Jason H Wasfy; Ariana M Albanese; Jeff C Huffman
Journal:  Psychosomatics       Date:  2016-12-09       Impact factor: 2.386

2.  Noncardiac chest pain: epidemiology, natural course and pathogenesis.

Authors:  Ronnie Fass; Sami R Achem
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

3.  Noncardiac chest pain--an Asia-Pacific survey on the views of primary care physicians.

Authors:  Ting Kin Cheung; Paul Wah Yonn Lim; Benjamin C Y Wong
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

4.  Patients dismissed from the hospital with a diagnosis of noncardiac chest pain: cardiac outcomes and health care utilization.

Authors:  Michael D Leise; G Richard Locke; Ross A Dierkhising; Alan R Zinsmeister; Guy S Reeder; Nicholas J Talley
Journal:  Mayo Clin Proc       Date:  2010-03-01       Impact factor: 7.616

5.  A Review of Esophageal Chest Pain.

Authors:  Enrique Coss-Adame; Satish S C Rao
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-11

6.  Origin of and therapeutic approach to cardiac syndrome X: results of the proton pump inhibitor therapy for angina-like lingering pain trial (PITFALL trial).

Authors:  Christoph-G Dietrich; Susanne Laupichler; Sven Stanzel; Ron Winograd; Oliver Al-Taie; Carsten Gartung; Andreas Geier
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.